Does XYLOMETAZOLINE Cause Hyperlipidaemia? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Hyperlipidaemia have been filed in association with XYLOMETAZOLINE (Metarivin Soln. 0.1%). This represents 9.3% of all adverse event reports for XYLOMETAZOLINE.
50
Reports of Hyperlipidaemia with XYLOMETAZOLINE
9.3%
of all XYLOMETAZOLINE reports
50
Deaths
47
Hospitalizations
How Dangerous Is Hyperlipidaemia From XYLOMETAZOLINE?
Of the 50 reports, 50 (100.0%) resulted in death, 47 (94.0%) required hospitalization, and 47 (94.0%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XYLOMETAZOLINE. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does XYLOMETAZOLINE Cause?
Off label use (161)
Abdominal distension (155)
Nausea (155)
Hyponatraemia (154)
Stress (152)
Multiple organ dysfunction syndrome (151)
Abdominal pain (149)
General physical health deterioration (148)
Appendicitis (147)
Vomiting (147)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which XYLOMETAZOLINE Alternatives Have Lower Hyperlipidaemia Risk?
XYLOMETAZOLINE vs XYREM
XYLOMETAZOLINE vs XYREM , /ML
XYLOMETAZOLINE vs YASMIN
XYLOMETAZOLINE vs YAZ
XYLOMETAZOLINE vs YTTRIUM Y-90